MORPHOLOGIC CHANGES OF NEUTROPHILS IN MYELODYSPLASTIC SYNDROME TREATED WITH RECOMBINANT HUMAN GRANULOCYTE COLONY‐STIMULATING FACTOR

por Toyama, Keisuke, Ohyashiki, Kazuma, Ohyashiki, Junko H., Takaku, Fumimaro
Publicado 1988

Hematologic and Cytogenetic Findings in Myelodysplastic Syndromes Treated with Recombinant Human Granulocyte Colony‐stimulating Factor

por Ohyashiki, Kazuma, Ohyashiki, Junko H., Toyama, Keisuke, Takaku, Fumimaro
Publicado 1989

Non‐radioisotopic and Semi‐quantitative Procedure for Terminal Repeat Amplification Protocol

por Ohyashiki, Junko H., Ohyashiki, Kazuma, Sano, Tetsuro, Toyama, Keisuke
Publicado 1996

A network biology approach evaluating the anticancer effects of bortezomib identifies SPARC as a therapeutic target in adult T-cell leukemia cells

por Ohyashiki, Junko H, Hamamura, Ryoko, Kobayashi, Chiaki, Zhang, Yu, Ohyashiki, Kazuma
Publicado 2008

Age-related decrease of miRNA-92a levels in human CD8(+ )T-cells correlates with a reduction of naïve T lymphocytes

por Ohyashiki, Michiyo, Ohyashiki, Junko H, Hirota, Ayako, Kobayashi, Chiaki, Ohyashiki, Kazuma
Publicado 2011

The C allele of JAK2 rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population

por Ohyashiki, Junko H, Yoneta, Masayuki, Hisatomi, Hisashi, Iwabuchi, Tamiko, Umezu, Tomohiro, Ohyashiki, Kazuma
Publicado 2012

Philadelphia Chromosome‐positive Chronic Myelogenous Leukemia with Deleted Fusion of BCR and ABL Genes

por Ohyashiki, Kazuma, Ohyashiki, Junko H., Iwabuchi, Hirotaka, Tauchi, Tetsuzo, Iwabuchi, Atsuhiro, Toyama, Keisuke
Publicado 1990

Chromatin Regulation by HP1γ Contributes to Survival of 5-Azacytidine-Resistant Cells

por Imanishi, Satoshi, Umezu, Tomohiro, Kobayashi, Chiaki, Ohta, Tomohiko, Ohyashiki, Kazuma, Ohyashiki, Junko H.
Publicado 2018

Effect of the extracellular component of bone marrow mesenchymal stromal cells from healthy donors on hematologic neoplasms and their angiogenesis

por Gladkova, Nina, Umezu, Tomohiro, Imanishi, Satoshi, Kawana, Chiaki, Ohyashiki, Junko H., Ohyashiki, Kazuma
Publicado 2020

Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients

por Tanaka, Masami, Oikawa, Kosuke, Takanashi, Masakatsu, Kudo, Motoshige, Ohyashiki, Junko, Ohyashiki, Kazuma, Kuroda, Masahiko
Publicado 2009

Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR-92a

por Ohyashiki, Junko H, Umezu, Tomohiro, Kobayashi, Chiaki, Hamamura, Ryoko S, Tanaka, Masami, Kuroda, Masahiko, Ohyashiki, Kazuma
Publicado 2010

Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: a possible biomarker to discontinue imatinib safel...

por Ohyashiki, Junko H, Ohtsuki, Kazushige, Mizoguchi, Izuru, Yoshimoto, Takayuki, Katagiri, Seiichiro, Umezu, Tomohiro, Ohyashiki, Kazuma
Publicado 2014

Teriflunomide restores 5-azacytidine sensitivity via activation of pyrimidine salvage in 5-azacytidine-resistant leukemia cells

por Imanishi, Satoshi, Takahashi, Ryoko, Katagiri, Seiichiro, Kobayashi, Chiaki, Umezu, Tomohiro, Ohyashiki, Kazuma, Ohyashiki, Junko H.
Publicado 2017

Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation

por Yoshizawa, Seiichiro, Umezu, Tomohiro, Saitoh, Yuu, Gotoh, Moritaka, Akahane, Daigo, Kobayashi, Chiaki, Ohyashiki, Junko H., Ohyashiki, Kazuma
Publicado 2018

Hypoxia-induced paclitaxel resistance in cervical cancer modulated by miR-100 targeting of USP15

por Nishi, Hirotaka, Ono, Masanori, Ohno, Shinichiro, Yamanaka, Zenta, Sasaki, Toru, Ohyashiki, Kazuma, Ohyashiki, Junko H., Kuroda, Masahiko
Publicado 2023

Downregulation of Plasma miR-215 in Chronic Myeloid Leukemia Patients with Successful Discontinuation of Imatinib

por Ohyashiki, Kazuma, Umezu, Tomohiro, Katagiri, Seiichiro, Kobayashi, Chiaki, Azuma, Kenko, Tauchi, Tetsuzo, Okabe, Seiichi, Fukuoka, Yutaka, Ohyashiki, Junko H.
Publicado 2016

Clinical Impact of Down-Regulated Plasma miR-92a Levels in Non-Hodgkin's Lymphoma

por Ohyashiki, Kazuma, Umezu, Tomohiro, Yoshizawa, Sei-ichiro, Ito, Yoshikazu, Ohyashiki, Michiyo, Kawashima, Hisashi, Tanaka, Masami, Kuroda, Masahiko, Ohyashiki, Junko H.
Publicado 2011

Immunosurveillance markers may predict patients who can discontinue imatinib therapy without relapse

por Yoshimoto, Takayuki, Mizoguchi, Izuru, Katagiri, Seiichiro, Tauchi, Tetsuzo, Furusawa, Jun-ichi, Chiba, Yukino, Mizuguchi, Junichiro, Ohyashiki, Junko H, Ohyashiki, Kazuma
Publicado 2014

A novel non-invasive monitoring assay of 5-azacitidine efficacy using global DNA methylation of peripheral blood in myelodysplastic syndrome

por Asano, Michiyo, Ohyashiki, Junko H, Kobayashi-Kawana, Chiaki, Umezu, Tomohiro, Imanishi, Satoshi, Azuma, Kenko, Akahane, Daigo, Fujimoto, Hiroaki, Ito, Yoshikazu, Ohyashiki, Kazuma
Publicado 2019